Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 2010; 104(01): 4-5
DOI: 10.1160/TH10-06-0347
DOI: 10.1160/TH10-06-0347
Theme Issue Editorial
New era of regenerative medicine for cardiovascular diseases
Financial support: This study was supported by Research Grants Council of Hong Kong, General Research Fund (No. HKU 7594/05M, HKU 7769/08M); Outstanding Researcher Award 2007–2008 (H.F.T); and Collaborative Research Fund of Hong Kong Research Grant Council (HKU 8/CRF/09).Further Information
Publication History
Received:
04 June 2010
Accepted
04 June 2010
Publication Date:
23 November 2017 (online)
-
References
- 1 Yang G, Kong L, Zhao W. et al. Emergence of chronic non-communicable diseases in China. Lancet 2008; 372: 1697-1705.
- 2 Orlic D, Kajstura J, Chimenti S. et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-705.
- 3 Siu CW, Liao SY, Liu Y. et al. Stem cells for myocardial repair. Thromb Haemost 2010; 104: 6-12.
- 4 Ransohoff KJ, Wu JC. Advances in cardiovascular molecular imaging for tracking stem cell therapy. Thromb Haemost 2010; 104: 13-22.
- 5 Boheler KR. Pluripotency of human embryonic and induced pluripotent stem cells for cardiac and vascular regeneration. Thromb Haemost 2010; 104: 23-29.
- 6 Kong M, Fadi A, Li RA. Translational potential of human embryonic and induced pluipotent stem cells for myocardial repair: Insights from experimental models. Thromb Haemost 2010; 104: 30-38.
- 7 Lian Q, Chow Y, Esteban MA. et al. Future perspective of induced pluripotent stem cell for diagnosis, drug screening and treatment of human diseases. Thromb Haemost 2010; 104: 39-44.